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have all been 
inconvenienced for several weeks by 
the loss of lab results on PHAMIS, I 
am happy to report that as of April 7, 
lab results are again available through 
PHAMIS. The problem arose with 
questions of confidence and the results 
being displayed for individual patients. 
We applaud the labors of our I/S and 
Laboratory staff who diligently worked 
many hours to "find the fix" and test 
and re-stress the system to reestablish 
our confidence in lab results. It is a 
mark of our concern and dedication to 
quality patient care that we endured 
these hardships until confidence was 
reestablished. 
Work on various search committees 
continues. The candidate for Chair of 
Surgery, Dr. Robert Bower, will be 
making a visit this week before 
rendering his decision. The search for 
Chief Operating Officer continues, and 
we are gratified by the high quality 
candidates interested in our institution. 
We initially interviewed four 
candidates. Two have been selected to 
return in the next few weeks for two-
day visits. Also, work on the Chief of 
Clinical Services has begun, with a 
revision of job description and paper 
review of interested candidates. 
Hopefully, on-site visits and interviews 
will begin shortly. 
Functional planning continues at a 
scheduled pace. Plans for the areas on 
the first floor for the new GI Lab and 
Pre-admission Testing, as well as the 
ER Fast Track site on the second floor 
(current location of Medical Staff 
Services) are proceeding according to 
schedule. At 17th & Chew, the fourth 
floor renovation for OB/GYN is 
underway. We have signed-off on the 
development of the Ambulatory/ 
Surgical wing, and a visit by state 
health officials to review the skilled 
nursing facility plans will take place in 
the next few weeks. 
Congratulations to our training 
programs in surgery, OB/GYN, and 
medicine. The results of the match 
continue to indicate interest among 
medical students in our programs, and 
places us competitively with the nations 
training programs. Our departments 
and divisions should be proud. 
Several of our departments and 
divisions have held discussions and 
conferences with our colleagues at 
Penn State's College of Medicine at 
The Milton S. Hershey Medical 
Center. Neurology has begun clinical 
conferences while orthopedic 
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physicians and division chiefs at our 
institution met with their counterparts 
at Penn State's College of Medicine. 
This is an ideal way to share programs 
and ideas and develop a true working 
relationship with our medical school 
affiliation. Congratulations to those 
who have already started the process, 
and I encourage all of us to explore 
avenues for discussion, cooperation, 
conferences, etc. 
On the managed care front, I am 
pleased to report that Prudential has. 
contracted with Lehigh Valley Hosp1tal 
for their global cardiac program. This 
task was not easy, and much credit 
needs to be given to the Divisions of 
Cardiothoracic Surgery and 
cardiology' the Department of 
Surgery, and Administration who 
worked with Prudential representatives 
to secure this contract for our 
institution. Also, in the managed care 
arena, Jack A. Lenhart, M.D., family 
practitioner, and John Jaffe, M.D., 
urologist, have agreed to serve as 
Medical Directors of our Physician-
Hospital Organization. Lawrence P. 
Levitt, M.D., neurologist, has accepted 
the position to chair the Care 
Management Committee. As we all 
know, we believe that the care 
management arm is the essential pi~ 
in promoting our PHO to employers m 
our community. We appreciate Jack's, 
John's, and Larry's acceptance of these 
positions and are very confident in 
their abilities to direct the IPA/PHO. 
Medical Staff participation in the 
Operations Improvement Program are 
highlighted by our Orthopedics 
Division working with Nursing and 
Physical Therapy to decrease length of 
stay. Impressive data can be obtained 
for your review from Peter Keblish, 
Jr., M.D., Chief of the Division of 
Orthopedics, or any of the orthopedic 
surgeons. Also, transcription 
turnaround time is improving, and we 
are continuing to work to achieve our 
goal of hard copy on the chart by 7 
a.m. the following day. Hard copy lab 
results have also been available at 
earlier times in. presence of the current 
PHAMIS problem. Our lab staff has 
worked hard to provide us with lab 
data as soon as it is available. 
Finally, I wish to thank Dick Fleming 
for his presentations to the General 
Medical Staff in March, to the Medical 
Executive Committee, and to members 
of our Medical Staff regarding the 
Cardiothoracic Surgery issues. We all 
have much concern for the future; 
however, I believe, that if we as a 
Medical Staff within our departments 
and divisions take ownership of patient 
care by addressing high standards of 
care for our patients, then we truly 
become aligned in our ultimate purpose 
-- quality patient care. 
Best Wishes and Happy Spring, 
A. Candio, M.D. 




A Reminder from Lehigh Valley Pharmaceutical ~ 
Association 
The hospital recently received notice 
from the Lehigh Valley Pharmaceutical 
Association about an old problem 
which seems to be growing again. 
Prescriptions containing no 
identification of the prescriber, other 
than a sometimes illegible signature, 
are being presented to pharmacists in 
the area. This often results in delays 
for the patient as the pharmacist tries 
to track down the prescriber. The 
valuable time of physicians and 
hospital personnel is often wasted in 
the process. This problem is especially 
acute with the physicians in the various 
residency programs at area hospitals. 
PHAMIS LastWord News 
To date, 30 offices have been 
connected to the PHAMIS network 
representing 144 physicians and 37 
work stations. Each month, 
approximately 250 physicians utilize 
the PHAMIS LastWord system more 
than 6,500 times to access our 
expanding clinical data base. 
Information Services is now accepting 
orders for physician office connections 
on a first-come, first-served basis. 
Please contact Information Services at 
402-1400 to initiate this process. 
Following is the schedule of classes for 
PHAMIS LastWord training for 
physicians, residents, and allied health 
personnel: 
• Tuesday, May 3- 1 to 3 p.m. 
• Tuesday, May 10- 6 to 8 a.m. 
This situation is easily prevented by 
having the prescriber's name preprinted 
on the prescription blank or by the use 
of a stamp containing the prescriber's 
name when using a hospital blank. In 
fact, Pennsylvania Act 1980-86, 
Section 1. (a) states, "The name of the 
physician writing a prescription for a 
drug shall be printed or stamped on the 
prescription form in addition to his 
signature." 
Please keep this in mind when you are 
writing prescriptions. Your 
cooperation is very much appreciated. 
• Tuesday, May 17- 5 to 7 p.m. 
• Thursday, June 9- 6 to 8 a.m. 
• Wednesday, June 15- 1 to 3 p.m. 
• Tuesday, June 21 - 5 to 7 p.m. 
• Thursday, July 7- 6 to 8 a.m. 
• Tuesday, July 12 - 1 to 3 p.m. 
• Wednesday, July 20 - 5 to 7 p.m. 
All classes will be held at 17th & 
Chew in the School of Nursing on the 
first floor. 
To register for a class or if you have 
any questions, please contact Diann 
Brey in Information Services at 
402-1404. 
Information Services welcomes your 
continued feedback and support. 
Please call 402-1404 for training/ 
refresher information or 402-8303 for 






While a patient is receiving heparin, 
you may occasionally run into a 
situation where the activated partial 
thromboplastin time (APTT) does not 
become as prolonged as would be 
expected while the patient is receiving 
intravenous heparin. This may occur 
. for one of four reasons: 
• Elevated factor I (Fibrinogen) 
• Increased factor Vlli 
• Decreased antithrombin lli level 
• Elevated platelet factor IV 
When this clinical situation occurs, a 
plasma heparin determination is 
warranted to avoid over-heparinization 
with the resultant increased propensity 
for hemorrhage to occur. 
Whenever the APTT results are lower 
than expected, a plasma heparin assay 
may be indicated to provide both a 
more accurate and safer monitoring of 
heparin therapy. To prove that the 
decreased APTT response is due to one 
of the above mentioned causes, 
monospecific factor assays can be 
performed for factors I, Vlll, 
Antithrombin ill, and platelet factor 
IV. In this instance, order a Heparin 
Resistance Prortle. The Heparin 
Resistance Prorde consists of the 
following tests: 
• Factor I level 
• Factor Vill level 
• Antithrombin ill level 
• Platelet factor IV level 
• Plasma heparin level 
Additional information can be found in 
the references as listed below: 
+ Glynn MFX. Heparin monitoring 
and thrombosis. Am I Clin Pathol 
1979; 71:397-400. 
+ Levine SP, Sorenson RR, Harris 
MA, Kniefiem LK. The effect of 
platelet factor 4 on assays of plasma 
heparin. Br J Haematol 1984; 57:585-
596. 
+ Marciniak E, · Gockerman IP . 
Heparin-induced decrease in circulating 
antithrombin m. Lancet 1977; 2:581-
584. 
+ Holm HA, Kalvenes S, Abildgaard 
U. Changes in plasma antithrombin 
during intravenous heparin therapy: 
Observations in 198 patients with deep 
venous thrombosis. Scand I Haemost 
1985; 35:564-569. 
+ Marci CD, Prager D. A review of 
the clinical indications for the plasma 
heparin assay. Lippincott 1993; 
99:547-550. 
If you have any questions regarding 
this issue, please contact David Prager, 
M.D., Medical Director, Hematology/ 
Coagulation Laboratory, at 433-6691, 
or Dolores Benner, Supervisor, 






Spectrum Apothecary Changes 
On Friday, April 8, Spectrum 
Apothecary closed its doors for the last 
time in its location at 1230 S. Cedar 
Crest Boulevard. On Monday, April 
11, a new pharmacy, known as Health 
Spectnun Pbarmacy Services, opened 
its doors in its new location, just off 
the atrium of the John and Dorothy 
Morgan Cancer Center. 
This move is in response to Health 
Spectrum's continued growth as a 
provider of high tech home care 
services. In addition to everyday 
prescription services, Health 
Spectrum Pharmacy Services 
specializes in home intravenous 
therapies and is staffed by pharmacists, 
nurses, and technicians specializing in . 
these areas. 
Hours of operation are Monday, 
Wednesday, and Thursday - 8:30 a.m. 
to 5:30p.m.; Tuesday and Friday-
7:30a.m. to 5:30p.m. 
For more information about the 
services offered, contact Health 
Spectrum Pharmacy Services at 
402-8444. 
Infection. Control Consultation Services 
The Infection Control Department of 
Lehigh Valley Hospital has recently 
developed a series of consultative 
services to cover a wide variety of 
needs. 
Activities offered through the services 
include: 
• Evaluation of standard infection 
control practices 
• Recommendations for program 
improvements 
• Evaluation or development. of 
exposure control plans 
• Provision of training programs 
A brochure which provides a complete 
description of the program is available 
through the Infection Control 
Department. 
For more information or a copy of the 
brochure, please contact Andrea 
Geshan, Director of the Infection 
Control Department and AIDS 
Activities Office, at 402-2413. 
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WallcAmerica for Healthier Babies 
On Sunday, April24, it's time for 
WalkAmerica for Healthier Babies, 
the nation's largest annual walk and 
fundraiser for the March of Dimes. 
This event raises money so that more 
babies will be born healthy. 
The success of WalkAmerica is 
important to the March of Dimes and 
to Lehigh Valley Hospital. Over the 
past 13 years, our hospital has received 
almost $300,000 in grants from the 
March of Dimes. We've used these 
dollars to purchase equipment and 
provide community programming. 
Lehigh Valley Hospital is getting 
involved by forming its own team of 
walkers. As friendly competition is 
encouraged, challenge one or more of 
your colleagues to get the most walkers 
and/or collect the most pledges. 
Our walkers will receive a hospital 
T -shirt and compete for individual and 
team prizes: 
• The person raising the most pledges 
wins two tickets to a 1994 Penn State 
football game 
News from Research 
A call for abstracts has been issued by 
the following organizations: 
• The American Heart Association for 
the 67th Scientific Sessions of the 
American Heart Association to be held 
on November 14, 1994 in Dallas, 
Texas. Submission due date is May 6. 
• The team raising the most pledges 
wins a gift basket 
• The team with the most walkers 
wins a gift basket 
• The youngest actual walker wins a 
Dorney Park season pass 
• The oldest actual walker wins a 
. dining/entertainment book 
• Individuals raising $200 or more in 
pledges will receive a Lehigh Valley 
Hospital sports bottle, fanny pack, and 
towel. 
Walk with us through the beautiful 
Lehigh Parkway, Union Terrace, and 
Cedar Beach. Together our team will 
walk seven miles to raise monies that 
are invested right here in the Lehigh 
Valley. Join Dr. Sussman and his 
family, your colleagues and friends on 
Sunday, April24. Let's all put our 
best foot forward for this worthwhile 
cause. 
For more information or to register, 
contact -Gail Pitsko, Lehigh Valley 
Hospital WalkAmerica Team Captain, 
in Public Relations, at 402-3001. 
• The International Society for 
Pharmacoepidemiology for the lOth 
International Conference on 
Pharmacoepidemiology to be held in 
Stockholm, Sweden on August 28, 
1994. Submission due date is May 20. 
For instructions, forms, and further 
information, please contact Kathleen 









of the HIV Patient 
by Donna Scott, R.D. 
Historically, nutrition has not been 
considered standard therapy in 
treatment of patients with HIV. 
However, nutrition intervention is 
becoming recognized as a key therapy 
in combating HIV I AIDS. One of the 
primary physiological considerations in 
HIV -infected patients is malnutrition. 
Malnutrition can exacerbate diminished 
immune function or independently 
minimize the quality of life and 
increase morbidity. Nutritional status 
can be reflective in the way patients 
respond to other therapies and 
medications. Well-nourished patients 
have a better quality of life and 
increased longevity. Early nutrition 
intervention may delay or prevent 
malnutrition and muscle wasting. 
Good nutrition will promote optimal 
functioning in all of the different 
systems, including the immune system. 
Complications from other physiological 
changes that occur in HIV I AIDS 
patients can be circumvented by 
nutrition intervention. The metabolic 
rate increases with the disease, 
therefore, the needs for increased 
calorie diet will help maintain body 
weight and preserve lean body mass. 
Some complications associated with 
HIV disease that can be improved/ 
treated with nutrition therapies include 
lactose and other food intolerances, 
anorexia, vitamin and mineral 
deficiencies, gastrointestinal 
dysfunctions (n/v/d), dysphagia, 
difficulty with dentition and 
malabsorption. 
Optimal nutrition can help strengthen 
the body and prevent tissue breakdown. 
What is meant by optimal/good 
nutrition for people with HIV I AIDS? 
A combination of increased 
carbohydrates, increased protein and 
moderate fat intake is the key. The 
foods selected should be nutrient dense 
to provide the right/correct balance of 
vitamins and minerals. 
A diet that is increased in complex 
carbohydrates is recommended (CHO's 
are the body's major source of energy 
and calories). Small, frequent meals (4 
- 6 times/a day) are usually better 
tolerated and can help meet metabolic 
stresses. 
• A complete multi-vitamin and 
mineral is recommended/day vs. 
megadoses of vitamins and minerals to 
provide sufficient essential nutrients. 
• Adequate food intake (30 - 35Kcal/ 
kg) with emphasis on adequate fluid 
intake. 
• Commercially available nutrition 
supplements are available and 
recommended when patients are unable 
to consume adequate Kcals. 
If patients continue with poor P.O. 
intake and have a functioning GI tract, 
enteral (TF) feeding is recommended. 
If unable to utilize GI tract, parenteral 
nutrition is recommended. 
For more information or for a full 
assessment and recommendations, 
contact Clinical Nutrition Services at 
402-8313 or 402-8378. 
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A Cause for Celebration! 
It's that time of year again-- Macy's is 
hosting its sixth annual Benefit 
Shopping Day on Tuesday, April 26, 
fro~ 10 a.m. to 10 p.m. at Macy's 
Lehigh Valley. For 12 continuous 
hours, you can shop amidst extra-
special excitement, with refreshments 
and various forms of entertainment 
featured on both levels of the store. 
In addition to the five discount coupons 
included with the purchase of your 
ticket, Macy's Benefit Day Shoppers 
will be registered to win spectacular 
prize packages, including: 
• Holland Vacation for Two (six 
days/five nights for two at the 
Five-Star Barbizon Centre Hotel 
and roundtrip air travel on 
KLM Royal Dutch Airlines) 
• Bermuda Get-Away for Two 
(seven days/six nights at the 
Belmont Hotel, Golf and 
Country Club, with unlimited 
free golf on the hotel's 18-hole 
golf course and complimentary 
breakfast each morning) 
• Thanksgiving in New York 
(four days/three nights at the 
Doral Park Avenue Hotel, VIP 
viewing of the Macy' s 
~giving Day Parade, and 
dmner for two at the Time and 
Again Restaurant) 
• $5,000 Shopping Spree in Fine 
Jewelry 
• $1,000 Men's Wardrobe 
• $1,000 Women's Wardrobe 
• Housewares Surprise Package 
Tickets are $5.00 each, the proceeds of 
which will benefit one of three special 
programs -- Friends of Nursin&, 
l.ehip Valley Hospice, and the John 
and Dorothy Morpn Cancer Center 
under the auspices of the Lehigh ' 
Valley Hospital Trust Fund. Tickets 
may be purchased at the Tree Top 
Shop (Cedar Crest & 1-78) and the 
Alcove Gift Shop (17th & Chew) or at 
other off-site locations as follows: 
• 1243 S. Cedar Crest- Laurie 
Gillespie (402-3031) 
• 2166 S. 12th Street - Tracy 
Kuhnsman (402-7441) 
• 2024 Lehigh Street - Debbie Strauss 
(402-1406) 
Buy your tickets today to join the fun 
and support a great cause! 
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News from the Office of Education 
All physicians in Pennsylvania must 
participate in CME activities sufficient 
to (a) fulfill the requirements of the 
American Medical Association 
Physician's Recognition Award (PRA), 
or (b) fulfill the requirements of the 
Pennsylvania Medical Society. These 
requirements are slightly different, but 
each requires participation in a 
minimum of 50 hours of CME each 
year, of which a minimum of 20 hours 
must be designated as Category 1. 
Category 1 CME must meet strict 
requirements including: 
• addressing a defined need 
• having specific objectives 
determined, based on the need defined 
Pool Trust News 
OB/GYN Resident Data 
CoUection Project Expansion 
In May 1993, the Pool Trustees 
approved $40,000 toward a project 
called the National Resident Data 
Collection Study. This study 
undertook the development of a system 
for resident data collection within the 
Department of OB/GYN, with 
implications for teaching programs at 
Lehigh Valley Hospital and nationally. 
At their February meeting, the Pool 
Trustees approved funding in the 
amount of $15,000 to expand the 
OB/GYN Resident Data Collection 
project in order to refine the existing 
program and to expand the project to 
include the Hershey Medical Center's 
Department of OB/GYN. 
• having teaching methods appropriate 
to the objectives 
• having defined methods of 
evaluation 
• demonstrating a budget sufficient to 
accomplish the objectives· and program 
• being free of commercial bias 
These standards are set by the 
Accreditation Council for Continuing 
Medical Education (ACCME). All 
organizations giving Category 1 CME 
credit are reviewed by the ACCME or 
a society authorized by it.· In the 
Lehigh Valley, the Lehigh Valley Area 
Health Education Center is accredited 
by the Pennsylvania Medical Society to 
approve programs for CME Category 1 
credit. 
RAC Protocols Receive 
Funding 
The Trustees approved the release of 
funds in the amount of $46,814 from 
the Institutional Research fund for the 
following Research Advisory 
Committee (RAC) protocols: 
• Disease Activity Follow-up in Patients with 
Inflammatory Bowel Disease; PI- James F. 
Reed ill, Ph.D., $5,000 
• The Effect of Inpatient Compreheasive 
Geriatric Assessment Intervention on Patient 
Care Outcomes; PI- Lisa Lacko, R.N., 
M.S.N., $32,474 
• Health-Related Quality of Life in Adult 
Community Acquired Pneumonia; PI - Barbara 
A. Salvadore, M.S., $4,500 
• Technique for Laparoscopic Vertical Handed 
Gastroplasty; PI- Clark Gerhard, M.D., 
$4,840 
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Publications, Papers and Presentations 
Robert V. Cmmninp, M.D., 
Chairperson, Department of Obstetrics 
and Gynecology, Larry R. 
Glazerman, M.D., Department of 
Obstetrics and Gynecology, and 
Stephen K. Klasko, M.D., Vice 
Chairperson and OB/GYN Residency 
Program Director, presented Re_iden_ 
Da_a Collec_ion Is Not Just S's and 
T's at the 1994 Council on Resident 
Education of Obstetrics and 
Gynecology and the Association of 
Professors of Gynecology and 
Obstetrics Annual Meeting held in 
Nashville, Tenn., on March 3. 
Peter A. Keblisb, M.D., Chief, 
Division of Orthopedic Surgery, co-
authored an exhibit at the American 
Academy of Orthopaedic Surgeons 61st 
Annual Meeting held recently in New 
Orleans, La. The scientific exhibit's 
primary author was Ashok Varma, 
M.D., recent Lehigh Valley Hospital 
resident, with other co-authors James 
F. Reed ill, Ph.D., Director of 
Research, and Frederick Buechel, 
M.D., Professor of Orthopaedics at 
New Jersey Medical Center. 
Lehigh Valley Hospital has been part ( 
of a multi-center study which was 
included in the clinical material of the 
exhibit. The exhibit addressed the 
important aspects of radiologic 
assessments of non-cemented total knee 
implants as they relate to clinical 
practice. 
Brian W. Little, M.D., Director of 
Education, presented Commercial 
Support and Guidance Practice 
Parameters at the Pennsylvania 
Medical Society's annual CME 
conference, CME In A Chan&in& 
Healthcare EnviroDDlent, which was 
held recently in Harrisburg. 
HowardS. Selden, D.D.S., 
endodontist, recently published a paper 
titled, Diagnostic Radiop'llpblC 
Findings and Symptom-Free Teeth. 
The paper appeared in the February 
1994 issue of the Journal of 
Endodontics. 
Upcoming Seminars, Conferences and Meetings 
Regional Symposium Series V 
Update: Management of Diabetes in 
ChDdren will, be presented on 
Thursday, April 21, from 1 to 4:30 
p.m., in the Auditorium of Lehigh 
Valley Hospital, Cedar Crest & I-78. 
Physicians, family practitioners, 
nurses, and other health care 
professionals interested in the 
management of diabetes in children 
will benefit from this program. 
Continued on Page 11 
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At the completion of the program, 
participants should be able to: 
• describe the outcomes associated 
with tight control of diabetes mellitus 
in children 
• discuss the state-of-the-art 
prevention, diagnosis, and treatment of 
renal complications in juvenile onset 
IDDM. 
Fourteenth Annual Update in 
Cardiology will be presented on 
Thursday, May 5, from 7:45a.m. to 
12:45 p.m., in the Auditorium of 
Lehigh Valley Hospital, Cedar Crest & 
1-78. 
Physicians and other health care 
professionals interested in the la~t 
breakthroughs in selected aspects m 
cardiology will benefit from this 
program. 
At the completion of the program, the 
participant should be able to: 
• identify the usefulness and long term 
outcome of coronary atherectomy 
• identify the usefulness and long term 
outcome of lasers and stents in 
coronary disease 
• identify the late outcome of coronary 
bypass surgery 
• treat lipid disorders in at-risk 
patients. 
Third Annual WUdemess Medicine 
Symposium will be presented on 
Saturday, May 14, from 7:15a.m. to 
4:45p.m., in the Auditorium of 
Lehigh Valley Hospital, Cedar Crest & 
1-78. 
Physicians, nurses, pre-hospital 
personnel, and others interested in 
wilderness medicine will benefit from 
this program. 
At the completion of this program, the 
participant should be able to: 
• describe safety strategies and 
survival techniques utilized by hunters 
• discuss the prevention, signs, , 
symptoms, and treatment of critical 
incident stress in the wilderness 
• describe common medical problems 
that occur during whitewater activities 
• explain techniques for creatively 
managing the airway 
• discuss the appropriate choice of 
clothing for outdoor activities 
• describe the prevention and 
management of injuries while mountain 
biking. 
Getting Employees Back to Work: 
Alternative Temporary Positiom will 
be presented on Friday, May 20, from 
8 a.m. to 3:45 p.m., in the Auditorium 
of Lehigh Valley Hospital, Cedar Crest 
& 1-78. 
Physicians, nurses, administrators, and 
insurance representatives concerned 
with Workers' Compensation costs will 
benefit from this program. 
At the completion of the program, 
participants should be able to: 
• identify steps for the development of 
a three-phase limited duty program 
• discuss examples of reasonable 
accommodations for workers with 
disabilities in the health care setting 
• outline the components and 
effectiveness of a team approach for 
managing employees return to work. 
For more information regarding these 
programs, please contact Human 
Resource Development at 402-4609. 
Continued on Page 12 
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Medical Grand Rounds 
Ethical Norms for Discontinuing 
Artificial Nutrition and Hydration 
will be presented by Father William 
Carr, Fairfield University, College of 
Arts and Sciences, Department of 
Philosophy, on Tuesday, April19. 
Hypothyroidism - A New Look at an 
Old Di!ease will be presented by 
Gilbert Daniels, M.D., Associate 
Professor of Medicine, Harvard 
Medical School, and Attending 
Physician, Massachusetts General 
Hospital, on Tuesday, April 26. 
Medical Grand Rounds are held at 
noon in the Auditorium of Lehigh 
Valley Hospital, Cedar Crest & 1-78. ( 
For more information, contact the 
Department of Medicine at 402-8200. 
Psychiatry Grand Rounds 
Non-Epileptic Seizures will be 
presented by Alexander Rae-Grant, 
M.D., neurologist, on Thursday, April 
21, from noon to 1 p.m., in the 
Auditorium of Lehigh Valley Hospital, 
17th & Chew. 
As lunch will be provided, pre-
registration is requested by calling the 
Department of Psychiatry at 402-2810. 
News from Health Promotion and Disease Prevention 
The Health Promotion and Disease 
Prevention Department of Lehigh 
Valley Hospital will present several 
free public lectures over the next few 
months. Sponsored by the Chronic 
Disease Education Committee of 
Lehigh Valley Hospital, the lectures 
include: 
Oh, My Aching Back will be 
presented by Thomas D. Meade, 
M.D., orthopedic surgeon, and Greg 
Salem, exercise specialist, on Tuesday, 
April 19, from 7 to 8:30p.m., in the 
Auditorium of Lehigh Valley Hospital, 
Cedar Crest & 1-78. 
Have you ever motivated yourself to 
try a new sport or exercise program, 
only to have your interest quickly 
dampened because of an injury? With 
the proper warm-up, cool-down, and 
exercise technique, many common 
back injuries, muscle strains, and bone 
sprains can be avoided. Learn how to 
prepare yourself for physical activity, ( 
and what to do if an injury does occur. 
Lyme Disease Update will be 
presented by David G. Beckwith, 
Ph.D., Administrator and Clinical 
Director, Health Network 
Laboratories, on Tuesday, April 26, 
from 7 to 8:30 p.m., in the Auditorium 
of Lehigh Valley Hospital, Cedar Crest 
& 1-78. 
With the summer and tick season just 
around the corner, the incidence of 
Lyme Disease will dramatically 
increase. Learn the facts about Lyme 
Disease and the precautions you can 
take to reduce your risk. Where the 
disease is most likely to occur, why 
immediate treatment is essential, and 
what to do if you've been bitten by a 
tick will also be discussed. 
Continued on Page 13 
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Be a Winner at Sports and Nutrition 
will be presented by Greg Salem, 
exercise specialist, and Donna Scott, 
registered dietitian, on Tuesday, May 
10 from 7 to 8:30p.m., in the 
A~ditorium of Lehigh Valley Hospital, 
Cedar Crest & I-78. 
There are many myths regarding 
exercise and food. Perhaps you have 
heard that exercising makes you eat 
more, or that if you eat more protein, 
you will build more muscle-- these 
claims are simply not true. Before you 
buy another "magical" supplement, 
come and learn the truths about many 
food. fallacies. In addition, different 
types of exercise and their benefits will 
be discussed. You too can feel better 
through exercise and healthy nutrition. 
Lean Star Cooking will be presented 
by Duncan Howdan, Associate 
Professor of Culinary Arts, 
Northampton County Community 
College, and Sandra Barillo, registered 
dietitian, on Thursday, May 19, from 7 
to 8:30p.m., in the Auditorium of 
Lehigh Valley Hospital, Cedar Crest & 
I-78. 
The Southwestern influence is being 
felt everywhere -- think about country 
line dancing, cowboy boots, and now 
the wonderful Tex-Mex food that is 
gaining popularity. In this 
presentation, the basics of low-fat 
cooking and a demonstration of how to 
"legalize" yummy Tex-Mex dishes ~11 
be covered. Imagine low-fat taco chips 
and fat-free bean dip, followed by 
healthy quesadillas and enchiladas. 
For more information or to register for 
any of the above programs, please 
contact the Health Promotion and 
Disease Prevention Department at 
821-2150. 
The Health Promotion and Disease 
Prevention Department also offers 
numerous other classes and programs 
for weight control, stress management, 
and smoking cessation which may 
benefit your patients. Some of the 
upcoming nutrition and weight control 
programs include: 
• 'lbink Light! Lowfat Living - This 
10-week program is a specially 
designed lowfat living plan that makes 
nutritious eating an easy fact of life. 
Beginning April 20, the program will 
be held on 10 consecutive Wednesdays 
from 7 to 8 p.m., in the O.R. 
Conference Room at Lehigh Valley 
Hospital, 17th & Chew. 
• R.E. W .A.R.D.S. - Have you been 
through a weight loss program and 
learned the basics of sound nutrition 
and weight management? Do you want 
more, but you are not sure what? The 
R.E.W.A.R.D.S. program is a follow-
up support group for "dieting 
veterans." The class will emphasize 
practicing stress management, 
developing social support systems, and 
will also include cooking 
demonstrations, and visits from an 
image consultant. Beginning April 19, 
the group will meet the third Tuesday 
of every month from 7 to 8:30p.m., in 
Conference Room 6 of Lehigh Valley 
Hospital, Cedar Crest & I-78. 
Continued on Page 1 4 
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• What's In the Cart?: Shopsmart -
Heart Health Prop'am - A registered 
dietitian will lead group tours 
highlighting "heart healthy" food 
choices. This will include the "new" 
food guide pyramid, convenience food 
items, label reading, and special 
occasion food selections. The group 
tour will be held at the Giant Food 
Store at Cedar Crest and Tilghman 
Streets in Allentown on Wednesday, 
April20, from 9:30 to 11 a.m.; 
Tuesday, May 3, from 7 to 8:30p.m.; 
and Wednesday, May 11, from 7 to 
8:30p.m. 
• For Sale or Lease - Springhouse 
Professional Center, 1575 Pond Road. Ideal 
for .physician's office. Approximately 1 ,000 
sq. ft. 
• For Sales or Lease - Medical/ Professional 
three-story office building at 1730 Chew 
Street, Allentown. Excellent condition with 
recent renovations. Approximately 6,800 sq. 
ft. for single or multiple specialty practice. 
Includes long-term parking lease at 
Fairgrounds. Potential telephone and 
dictations systems. 
• For Sale -- Office building at Northeast 
corner of 19th and Turner Streets in 
Allentown. Upper level - 2,400 + sq. ft., large 
waiting room, two large consultation rooms, 
five exam rooms, etc. Lower level - 2,300 + 
sq. ft. Parking lot for 16 cars. 
• For Lease -- Office to sublet on Monday. 
Tuesday, Thursday, and Friday. 950 sq. ft. 
Common waiting area. Lakeside Professional 
Building, Quakertown. 
• For Lease -- Monday time slot available in 
the medical office building on the campus of 
Gnaden Huetten Memorial Hospital in 
Lehighton. 
• For Lease -- Medical-professional office 
space located on Route 222 in Wescosville. 
Two 1 ,000 sq. ft. offices available or combine 
to form larger suite. 
For more information about the above 
programs, please contact the Health ( 
Promotion and Disease Prevention 
Department at 821-2150. 
• For Lease - Slots are currently available for 
the Brown Bag suite at Kutztown Professional 
Center. Ideal for satellite location. 
• For Lease - Large, newly remodeled, 
completely furnished medical office space 
available for subleasing/time share at Cedar 
Crest Professional Park. Top of the line 
telephone system. Transcription and 
computer system with electronic billing 
available. 
• For Lease -- Medical office space located in 
Peachtree Office Plaza in Whitehall. One suite 
with 1 ,500 sq. ft. (unfinished - allowance 
available), and one 1,000 sq. ft. finished suite. 
• For Lease -- Specialty practice time-share 
space available in a comprehensive health care 
facility. Riverside Professional Center, 4019 
Wynnewood Drive, Laurys Station. Half- or 
full-day slots immediately available. 
• For Lease - Professional office space 
available in an established psychology and 
psychotherapy practice at 45 North 13th 
Street, Allentown. Large, warm Victorian 
building in a relaxed atmosphere. Secretary 
and billing available and included in some 
leases. Furnished or unfurnished full offices 
and sublets available. Utilities included. 
For more information or for assistance in 
finding appropriate office space to meet your 
needs, contact Joe Pilla, Physician Relations~ 
Rep, at 402-9856. 
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WHO'S NEW 
The Who's New section of Medical 
Stqff Progress Notes contains an 
update of new appointments, address 
changes, newly approved priVileges, 
etc. Please remember that each 
department or unit is responsible for 
updating its directory, rolodexes, and 
approved privilege rosters. 
Medical Staff 
Appointment 
Andrew J. Pestcoe, DO 
Tomkin Otolaryngology Associates, PC 
2895 Hamilton Blvd. 
Suite 102 
Allentown, PA 18104 
(610) 432-8551 
Department of Surgery 
Division of Otolaryngology 
Provisional Courtesy 
Additional Privileges 
Fred l.aufer, MD 
Department of Family Practice 
Active 
Flexible Sigmoidoscopy 
Hu&h S. Gallagher, MD 
Department of Medicine 
Division of Cardiology 
Active 
Transluminal Extraction Catheter 
Atherectomy (TEC) 
Stephen T. Olex, DO 
Department of Medicine 
Division of Cardiology 
Active 
Transluminal Extraction Catheter 
Atherectomy (TEC) 
Robert J. Oriel, MD 
Department of Medicine 
Division of Cardiology 
Active 
Transluminal Extraction Catheter 
Atherectomy (TEC) 
Change of Status 
Robert J. Gary, MD 
Department of Surgery 
Division of Urology 
From Active to Courtesy 
Frank P. Matrone, DO 
Department of Family Practice 
From Referring to Provisional 
Courtesy 
Unit Director Appointment 
Y ehia Y. Mishriki, MD 
4S 




William B. Dupree, MD 
Department of Pathology 
Chief, Section of GYN Pathology 
Vincent R. IAlcente, MD 
Department of Obstetrics and 
Gynecology 
Chief, Division of Gynecology 
Chief, Section of Pelvic Reconstructive 
Surgery 
Gregory J. Radio, MD 
Department of Obstetrics and 
Gynecology 
. Chief, Section of Primary OB/GYN 
Continued on Page 1 6 
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Practice Changes 
Robert B. Kevitch, MD 
will be joining Plastic Surgeons 
Professional Group, Inc. 
(Effective April1, 1994) 
Brian SteUo, MD 
• No longer associated with 
Trexlertown Medical Center 
• Joining Family Practice - Lehigh 
Valley Health Network 
Qobn W. Reinhart, MD) 
(Effective April 1, 1994) 
Resignation 
Stephen J. Barrett, MD 
Department of Psychiatry 
Consulting 
Address Changes 
Robert H. Dixon, MD 
Emory University 
Department of Pediatrics 
Division of Critical Care/Emergency 
Medicine 
1405 Clifton Road 
Atlanta, GA 30322 
Deidre J. Greene, MD 
4455 Haverstraw Drive 
Dunwoody, GA 30338 
Robert B. Kevitch, MD 
Plastic Surgeons Professional Group, 
Inc. 
1230 S. Cedar Crest Blvd., Suite 204 
Allentown, PA 18103 
(610) 432-1953 
(Effective April 1, 1994) 
Robert M. Russo, DO 
3654 Old Philadelphia Pike 
Bethlehem, PA 18015 
Brian SteUo, MD 
Family Practice- Lehigh Valley Health 
Network · 
2200 Hamilton Street 
Suite 308 
Allentown, PA 18104 
(610) 434-7641 
(Effective April 1, 1994) 
New Fax Number 





Pamela VandeniJer&, CRNP 
Physician Extender 
Professional - CRNP 




A Service of LEH$HVAILEY 
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Reference Ranges, Sensitivity, Specificity and their 
Application to the Diagnostic Accuracy of MI Proides 
The terms sensitivity and specificity have 
at least two meanings for a laboratorian 
namely technical and diapostic. Technical 
sensitivity of test deals with the ability of 
the test to measure very low levels of an 
analyte and specificity, the ability of the 
test to measure only the analyte in question 
to the exclusion of all other compounds. 
However, the diagnostic sensitivity and 
specificity defines a laboratory tests' 
diagnostic accuracy. This is the concept 
that was referred to in relationship to the 
new MCKMB measurement in the last 
newsletter. 
Sensitivity indicates the frequency of 
positive test results in patients with a 
particular disease, whereas specificity 
indicates the frequency of negative test 
results in patients without that disease. 
The predictive value of a positive test 
result indicates the frequency of diseased 
patients in all patients with positive test 
results. The predictive value of a negative 
test result indicates the frequency of non-
diseased patients in all patients with 
negative test results. The efficiency of a 
test indicates the percent of patients (both 
diseased and non-diseased) correctly 
classified by the test. 
By understanding these definitions, how 
does the laboratory use them to 
set the reference range for a test or 
combination of tests? The limits placed on 
the reference range have a direct influence 
on the diagnostic accuracy for that test. In 
the MCKMB study 140 patients were 
measured to include a percentage with MI, 
a percentage without MI and a percentage 
with no MI but another medical condition. 
We know that other medical problems can 
produce CKMB. Final discharge 
diagnoses were obtained for each patient. 
This means that the "gold standard" to 
evaluate the test is the physicians diagnosis 
which along with the testing accuracy 
influences the setting of the reference 
range and ultimately the diagnostic 
accuracy. For each of the 140 patients we 
have a measured MCKMB and total CK, a 
diagnosis and a calculated relative index 
(RI) in percent. From this data we can 
determine true positives, false negatives, 
true negatives and false positives for any 
level of MCKMB and RI. From that data 
a series of calculations were performed to 
determine sensitivity, specificity, efficiency 
and predictive value of positive test and 
negative test at MCKMB values from 2-18 
and RI percentages from 0-8. This 
produced a long table of numbers. 
To pick a reference range from these 
calculations the nature of the disease being 
diagnosed must be considered along with 
the following concepts: 
A. Sensitivity of the test may vary 
with the severity of the disease and 
should be maximized for serious 
diseases that are treatable, should 
not be missed where false positives 
do not lead to serious 
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psychological or economic trauma 
to the patient. Examples: 
infectious disease, hypertension 
and hyperlipidemia. 
B. Specificity may vary with the type 
of control group and should be 
maximized for serious diseases that 
are not treatable or curable and/or 
a false positive results in serious 
psychological or economic trauma 
to the patient. Example: HIV, 
Tay Sachs, selected metabolic 
diseases. 
C. Efficiency should be maximized 
for a treatable but serious disease 
where false positives and false 
negatives are equally serious and 
damaging. Examples: MI, SLE, 
Diabetes Mellitus. 
Applying these concepts we reviewed the 
table of calculations of sensitivity, 
specificity and efficiency for this study of 
140 patients and chose the reference range 
for which the efficieDCJ of the test was 
highest. 
Emdency Sensitivity 
MCKMB = 5 91 84 
RI% = 4 
MCKMB = 5 80 93 
RI% = 0 
Electrophoresis 88 64 
CKMB = 5 
RI = 4 
An interpretation of the above abbreviated 
table produces the following: 
1. The maximum efficiency occurred 
at MCKMB of 5 and RI of 4% our 
current reference range. 
2. Dropping the use of the RI 
decreased the efficiency of the 
testing from 91 to 80. This is why 
the RI is one of the parameters 
used in our report. 
3. Electrophoresis is not as accurate a 
testing methodology but its 
specificity is greater than the new ( 
mass molecule measurement. 
Actually this was appreciated by 
most physicians who observed that 
negative Mis would always be 
negative by the electrophoresis 
method. This is to be expected as 
the electrophoresis method is not 
as sensitive and really did not 
detect CKMB below 4 ng/ml. 
Now having outlined the protocol and 
criteria that the laboratory uses to change a 
method and/or introduce new tests why did 
Health Network Laboratories change from 
electrophoresis to MCKMB? The 
efficiency only improved 3% with a loss of 
specificity. 
1. Within 2 years all clinical 
laboratories will use this MCKMB 
test. In fact this test with its very 
superior antibody is considered to 






2. Electrophoresis could not be 
provided STAT. The protocol for 
the Chest Pain Clinical Path., the 
ER and the Trauma Service called 
for the rapid diagnosis of a MI and 
STAT testing. 
3. The MCKMB test allows for the 
completion of the 3 specimen serial 




hour period. This means that 
negative patients can be moved 
sooner to a less intensive less 
costly bed. 
CKMB is a low molecular weight 
enzyme which can be released 
from the cytoplasm of the cell 
without the cell dying. LD is a 
high molecular weight enzyme and 
the cell must die to release it into 
circulation. The CKMB released 
into the blood due to these non MI 
"cardiac insults" is detected by the 
more analytically sensitive mass 
molecule measurement. The 
John J. Shane, MD 
Chairperson, Pathology 
Gerald E. Clement, Ph.D. 
Director, 
MCKMB serial presentation for this non 
MI "insult" will not be the classic rise and 
fall of the isoenzyme. Although this 
increase in MCKMB due to a cardiac 
"insult" may tend to cloud the tests use for 
diagnosis of an overt MI, its measurement 
is diagnostically important. It is thought 
that identifying a patient that has 
experienced a non MI cardiac insult is 
critical information for the long term 
treatment of the patient. This may be the 
first documentation that the patient has 
experienced a cardiac problem which may 
be a precursor to an overt MI. Two 
examples of this type of presentation were 
illustrated in the last newsletter. 
David G. Beckwith, Ph.D. 
Clinical Director, 






P & T Highlights 
The following action were 
taken at the March 14, 1994 
Pharmacy and Therapeutics 
Committee Meeting 
James A. Giardina, 
Director of Pharmacy 
FORMULARY ADDITION REQUEST 
FOR NOW 
Mesalamine (Pentasa, MMD) is a new controlled 
release formulation of aminosalicylate, which is 
slightly different from Asocol, the other 
Mesalamine formulation. It is indicated for the 
induction of remission and treatment of patients 
with mild to moderate active ulcerative colitis. It 
also appears to have efficacy in the treatment of 
Crohn's disease. Although mesalamine's 
mechanism of action is unknown, it is thought to 
work locally rather than systemically, possibly 
through modulation of the inflammatory response, 
especially leukotriene production. Pentasa is 
formulated in an ethylcellulose-coated, 250mg 
controlled release capsule, which releases active 
medication in a pH dependent fashion to provide 
active drug to both the small & large bowel. 
Asocol is released in the distal part of the small 
bowel, when the gut pH is > 7). Elimination is 
thought to occur through the fecal route, with up 
to 30% excreted in the urine. Mesalamine should 
be used cautiously in hepatically impaired 
patients. Mesalamine has caused renal 
impairment, including nephropathy and acute & 
chronic interstitial nephritis. Because of this, it 
should also be used cautiously in renally impaired 
patients. Other adverse events include acute 
intolerance syndromes (which may be difficult to 
distinguish from disease flare up), headache, rash 
and GI effects (diarrhea, N/V, abdominal pain, & 
dyspepsia). Mesalamine is contraindicated in 
patients with hypersensitivity to its ingredients. 
It's safety in pregnancy and lactation has not been 
established and caution is advised. It is not 
recommended for children. Little information is 
available on drug interactions, however, because 
mesal amine's release & absorption is pH 
dependent, potential drug interactions exist with 
other medications that alter GI pH. Baseline and 
periodic renal and liver function monitoring is 
recommended. The usual dose is one gram four 
times daily, with approximately 20-30% 
absorbed. No comparative studies have been 
performed between Pentasa and Asocol. Because 
of the theoretical advantage of Pentasa and also 
because product usage is low, both agents will be 
evaluated after one year. While Pentasa is 
generally well tolerated and produces fewer side 
effects than Sulfasalazine, approximately 10 -
20% of patients intolerant to sulfasalazine will not 
tolerate Mesalamine. 
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FOR SEIZURE CONTROL 
Gabapentin (Neurontin, PD) is the second new 
antiepileptic agent approved in 1993. It is a 
GABA analogue, with an unknown mechanism of 
action. It does not interact with GABA receptors. 
Gabapentin is indicated as adjunctive therapy in 
the treatment of partial seizures with & without 
secondary generalization in adults with epilepsy. 
Gabapentin's bioavailability is inversely related to 
dose, i.e. as the dose increases, the bioavailability 
decreases. In the usual dose range, the 
bioavailability is about 60% . Food has no effect 
on the rate or extent of absorption. It is largely 
unbound to plasma protein. Gabapentin is not 
appreciably metabolized and is excreted 
unchanged in the urine. Gabapentin has an 
elimination half life of 5 to 7 hours, which is 
directly related to creatinine clearance. In elderly 
patients and in patients with impaired renal 
function, clearance is reduced. Gabapentin is 
removed from the circulation via hemodialysis. It 
is contraindicated only in patients who have 
demonstrated hypersensitivity to it. Gabapentin 
has not been studied in pregnant or nursing 
women, and it is recommended only if the 
potential benefits outweigh the fetal risk. It has 
been shown to be teratogenic in several animal 
models. The most common adverse events in 
combination with other antiepileptic agents are 
somnolence and ataxia (which appear to be dose 
related) as well as fatigue and nystagmus. No 
Table 1 - Gabapentin Dosage in Renal Impairment 
Renal Function 
drug interactions have been documented, 
however, there are reports of increased phenytoin 
levels with Gabapentin dosages of 900mg/day & 
decreased valproate levels with Gabapentin doses 
of 300 & 600mg/day. The importance of these 
observations remain to be determined. 
Gabapentin is recommended for adults & children 
over 12 with a probable effective dose of 900-
1800mg/day. It is given three times daily without 
regard to food. Dose titration is recommended, 
with 300mg given on day 1 at bedtime, 300mg 
given twice on day 2, then 300mg given three 
times on day 3. Dose escalation to 2400mg has 
been well tolerated in clinical trials, and some 
patients received 3600mg/day for short periods. 
The maximum time between doses should not 
exceed 12 hours. Table 1 depicts dosage 
recommendations in renal impairment and 
hemodialized patients.Gabapentin plasma levels 
need not be monitored to optimize therapy. If 
gabapentin is discontinued and/or alternative 
anticonvulsant therapy is added, this should be 
done gradually over at least one week. 
Gabapentin comes in 1 OOmg, 300mg & 400mg 
capsules with respective costs of $0.21, $0.47 & 
$0.52. 
Dosage adjustment in patients with compromised 
renal function or undergoing hemodialysis is 
recommended as follows: 
Creatinine Clearance Total Daily Dose Dose Regimen 
(ml/min) (mg/day) (mg) 
>60 1200 400mg TID 
30-60 600 300mg BID 
15-30 300 300mg QD 
- <15 150 300mg every other day 
Hemodialysis --- LD of 300-400mg then 




Table 2 - Formulary Deletions 
Product Action Reason 
Desitin Ointment R A 
Saratoga Ointment D A,L 
Torecan Suppos. • D A,L 
(thiethylperazine) 
Tucks Ointment• D A,L 
• No longer available + Available from SPD 
93 FDA NEW DRUG APPROVALS 







Limit Desitin to 
pediatrics 
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NURSING IV GUIDELINE CHANGES 
Several changes were made to the Nursing IV Guidelines, which are depicted in Table 4. The { 
concentration for Magnesium Infusions in obstetric patients was also changed from 1 Og/500ml to 
20g/500ml given conversion to the Horizon IV pump, which has built-in free flow protection. 
Table 4 - Nursing IV Guideline Additions 
FLOW RATE FLOW RATE MED/SURG NURSES CRITICAL CARE 
MEDS FOR FOR IV DILUTION VALIDATED IN MONITORED 
IV PUSH INFUSION OR DRIP PUSH CHEMO BEDS 
DILUTION DILUTION 
OR DRIP PUSH OR DRIP PUSH 
Phenytoin Maximum rate of Doses >soomg Yes Yes Yes Yes Yes Yes 
Sodium SOmg/min in in IOOml NSS 
(Dilantin) adults for doses and doses:::, 
~SOOmg. 1500 in 150ml 
No I.V. push for NSS infused 
doses >500mg. through a 0.22 
micron filter at a 
maximum rate 
of 25mg/min. 




Pamidronate* N/A 60mg & 90mg Yes No Yes No Yes No 
(Aredia) doses can be 
diluted in a -
minimum of 
SOOml DSW and 
infused over 4 








• The Medical Literature and Clinical practice support shorter infusion times than the manufacturer recommended 24 hours. 
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. THE TROUBLE WITH DARVOCET 
( .1e Committee discussed potential for patients to consume excessive amounts of Acetaminophen (AP AP) from 
either AP AP containing combination analgesics or Darvocet N 1 00 alone. The Committee is aware that 
patients have unknowingly been given in excess of 4g/day. Several options that the Committee discussed 
included whether Darvocet N 1 00 should be taken off the formulary or removed from Preprinted Orders. 
Darvocet N 100 has received much focus as it is the highest containing APAP product on Formulary. Table 5 
lists the AP AP containing products currently on Formulary together with their AP AP content. The Committee 
asked for a random review to determine daily AP AP intake prior to a decision. 
BRAND NAME AP AP CONTENT PER TAB/CAP 
Darvocet N 100 
Fioricet 
Percocet 
Tylenol with Codeine 
Tylenol 
Tylenol Extra Strength 







At the time of standardization on Nizatidine as the preferred oral H2 Blocker, the Pharmacy conducted a 
random survey of community prices for the most used oral H2RAs. This data was updated to respond to 
Jncems that Nizatidine prices would be dramatically increased in the community to compensate for the special 
hospital pricing. The data seem to allay the concern. 
Table 5 - Selected Oral H2RA Prices in the Community 
DRUG Axid 150mg Pepcid 20mg Zantac 15()mg 
DATE OF 5/93 1/94 5/93 1194 5/93 1194 
SURVEY 
PHARMACY A $99.17 $103.13 $98.48 $102.58 $109.54 $113.92 
VARIANCE + 4% +4% + 4% 
PHARMACY B $90.00 $100.23 $88.89 $ 96.99 $92.69 $ 94.80 
VARIANCE + 11% + 9% + 2% 
PHARMACY c $97.99 $ 97.99 $90.99 $ 96.99 $91.99 $ 96.99 
VARIANCE 0% +7% +5% 
PHARMACY D $80.19 $ 76.79 $84.88 $ 85.49 $76.39 $ 79.56 
VARIANCE - -4% +.0.7% +4% 
., 
PHARMACY E $89.95 $ 93.50 $89.50 $ 92.95 $98.95 $102.75 
ll VARIANCE +4% + 4% +4% 
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